FIELD: medicine. SUBSTANCE: method involves using lymphocyte suspension separated from patient blood treated with heparin, by means of centrifuging on 1.077 density gradient. Incubation of lymphocyte suspension separated from blood lasts 90 min with drug tested for toxic properties to be added. Then, after 2 min long centrifuging, incubation is continued with sheep erythrocytes added during 18 h. Index of lymphocyte sensitivity to the tested preparation is calculated as lymph toxicity index from a formula: LTI= (% quantity of E-rosette-forming complex in experiment) / (% quantity of E-rosette-forming complex in control sample). The LTI <1.0 being the case, conclusion is drawn concerning inhibited lymphocyte E-receptors motility. The LTI value being greater than or equal to 1.0, conclusion of no lymph toxicity available is to be drawn. EFFECT: high accuracy and sensitivity of the method; enhanced effectiveness in differentiating toxic and auto immune states.
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING PATHOLOGICAL PROCESS STAGE IN TESTS FOR EVALUATING FUNCTIONAL ACTIVITY OF LYMPHOCYTES | 1997 |
|
RU2175769C2 |
METHOD OF DETERMINATION OF RELATIVE AND ABSOLUTE COUNT OF ZERO LYMPHOCYTES | 1997 |
|
RU2166759C2 |
METHOD OF DIAGNOSIS OF HEPATITIS | 0 |
|
SU1767431A1 |
METHOD FOR DETERMINING STIMULATED NEUTROPHIL PHAGOCYTOSIS | 1997 |
|
RU2165621C2 |
DIAGNOSIS OF PERIODONTAL DISEASES IN PATIENTS WITH BRONCHIAL ASTHMA | 2014 |
|
RU2584028C1 |
METHOD OF DETERMINING STATE OF IMMUNOREACTIVITY | 0 |
|
SU1123703A1 |
METHOD OF PSORIASIS TREATMENT | 2007 |
|
RU2361605C2 |
METHOD FOR ESTIMATION OF ALUMINIUM INFLUENCE ON IMMUNE STATUS | 2016 |
|
RU2629597C1 |
METHOD FOR ACCOMPANYING TREATMENT OF LYMPHOBLAST LEUCOSIS | 2006 |
|
RU2320367C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING INFECTIOUS COMPLICATIONS IN PATIENTS WITH MALIGNANT LYMPHOPROLIFERATIVE DISEASES AND RECEIVING PROGRAM CHEMOTHERAPY | 2014 |
|
RU2587757C1 |
Authors
Dates
2000-07-10—Published
1997-07-08—Filed